Alpha-Lipoic Acid to Help Advanced Lung Cancer Treatment
Treatments studied
Part of Cancer, Lungs & breathing clinical trials.
This study tests whether adding alpha-lipoic acid (a natural antioxidant supplement) to standard chemotherapy helps patients with advanced non-small cell lung cancer feel better and live longer. Researchers want to see if this supplement reduces side effects and improves how well the chemotherapy works.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have stage III or IV non-small cell lung cancer (NSCLC) that cannot be surgically removed
- Your overall health and ability to do daily activities are good enough (ECOG score 0–2, meaning you can do light to moderate activities)
- Your cancer does not have a known driver mutation (a specific genetic change that would require a different treatment)
- Your blood counts, liver, and kidney function are healthy enough for treatment
- You are not pregnant or breastfeeding, and you are not taking iron supplements or thyroid medications that could interfere with the study drug
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a combination of radiation therapy, chemotherapy, and two newer cancer-fighting drugs (tislelizumab and surufatinib) for patients with Stage III non-small cell lung cancer that cannot be surgically removed. The goal is to see if this combination works better than standard treatment.
This study tests a combination of chemotherapy and immunotherapy in people with advanced non-small cell lung cancer that has spread or cannot be removed with surgery. The goal is to see how well this treatment works in patients with different levels of daily activity.
This trial tests a new study drug called PF-08634404 combined with standard chemotherapy for people with advanced lung cancer that has not been treated before. It aims to see if this combination works better than chemotherapy alone.
This trial tests a combination of a targeted chemotherapy bead injection into lung arteries, an oral anti-cancer drug, and an immunotherapy for advanced non-small cell lung cancer that has not responded to two prior treatments. It aims to see if this triple approach can help patients who have limited options left.
This study tests whether a probiotic supplement (LR607) can help patients with newly diagnosed non-small cell lung cancer—a common type of lung cancer. Probiotics are beneficial bacteria that may help your immune system fight cancer alongside standard treatments.
This trial tests whether adding a fiber supplement to standard immunotherapy can help treat advanced non-small cell lung cancer. It's for people whose tumors have high PD-L1 levels and no treatable genetic mutations.
Hear when a new Advanced Non Small Cell Lung Cancer (NSCLC) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.